Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers

References

• Ministry of Social Affairs. Omreglering av apoteksmarknaden (SOU 2008:4). Huvudbetänkande av Apoteksmarknadsutredningen Del 1 & 2. [Re-regulation of the Pharmacy Market - Report from the Inquest of the Pharmacy Market] [in Swedish]. English summary: https://www.regeringen.se/49b6a8/contentassets/f2990e583ef44add8866fc67ae1ca253/sammanfattning-av-omreglering-av-apoteksmarknaden-pa-engelska (Accessed 14 augusti 2020).
   Google Scholar
• Noone J, Blanchette CM. The value of self-medication: summary of existing evidence. J Med Econ. 2018;21:201–221.
   PubMed Web of Science ®Google Scholar
• Håkonsen H, Andersson Sundell K, Martinsson J, Hedenrud T. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market. Health Policy. 2016;120:327–333.
   PubMed Web of Science ®Google Scholar
• Droege M, Maniscalco M, Daniel KL, Baldwin HJ. Consumers’ risk perceptions of prescription and over-the-counter medications. J Pharm Tech. 2007;23:142–147.
   Google Scholar
• Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16:821–847.
   PubMed Web of Science ®Google Scholar
• Tittarelli R, Pellegrini M, Scarpellini MG, Marinelli E, Bruti V, di Luca NM, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci. 2017;21:95–101.
   PubMed Web of Science ®Google Scholar
• Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75:552–559.
   PubMed Web of Science ®Google Scholar
• Gedeborg R, Svennblad B, Holm L, Sjögren H, Bardage C, Personne M, et al. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol Drug Saf. 2017;26:518–527.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Sørensen HT, Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 2018;362:k3426.
   PubMedGoogle Scholar
• Vogler S. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries - an overview. GaBI J. 2012;1:44–51
   Google Scholar
• The Swedish Agency for Public Management. A re-regulated pharmacy market – final report (2013:7). http://www.statskontoret.se/in-english/publications/2015-summaries-of-publications/a-re-regulated-pharmacy-market--final-report-20137. Accessed 10 Sept 2020.
   Google Scholar
• Håkonsen H, Andersson SK. Pharmaceutical pricing policies in Norway and Sweden. In: ZUD Babar (ed): Pharmaceutical prices in the 21st century Springer International Publishing. Switzerland: ISBN 978-3-319-12168-0; 2015.
   Google Scholar
• Godman B, Persson M, Miranda J, Skiöld P, Wettermark B, Barbui C, et al. Changes in the utilization of venlafaxine after the introduction of generics in Sweden. Appl Health Econ Health Policy. 2013;11:383–393.
   PubMedGoogle Scholar
• Godman B, Persson M, Miranda J, Barbui C, Bennie M, Finlayson AE, et al. Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from S weden and potential implications. JPHSR. 2013;4:139–150
   Google Scholar
• Frisk P, Rydberg T, Carlsten A, Ekedahl A. Patients’ experiences with generic substitution: a Swedish pharmacy survey. JPHSR. 2011;2:9–15
   Google Scholar
• Olsson E, Svensberg K, Wallach-Kildemoes H, Carlsson E, Hällkvist C, Kaae S, et al. Swedish patients’ trust in the bioequivalence of interchangeable generics. What factors are important for low trust? Pharm Pract (Granada). 2018;16:1298.
   PubMed Web of Science ®Google Scholar
• Kohli E, Buller A. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs. South Med J. 2013;106:155–160.
   PubMed Web of Science ®Google Scholar
• Halme M, Linden K, Kääriä K. Patients’ preferences for generic and branded over-the-counter medicines: an adaptive conjoint analysis approach. Patient. 2009;2:243–255.
   PubMedGoogle Scholar
• Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015;5:e008915.
   PubMed Web of Science ®Google Scholar
• Håkonsen H, Toverud EL. A review of patient persectives on generic substitution: what are the challenges for optimal drug use? GaBI J. 2012;1:28–32.
   Google Scholar
• Dunne SS. What do users of generic medicines think of them? A systematic review of consumers’ and patients’ perceptions of, and experiences with, generic medicines. Patient. 2016;9:499–510.
   PubMedGoogle Scholar
• Fraeyman J, Peeters L, Van Hal G, Beutels P, De Meyer GR, De Loof H. Consumer choice between common generic and brand medicines in a country with a small generic market. J Manag Care Spec Pharm. 2015;21:288–296.
   PubMed Web of Science ®Google Scholar
• Bäckryd E. Gender differences in dispensed analgesics in Sweden during 2006-2015 - an observational, nationwide, whole-population study. Int J Women’s Health. 2018;10:55–64.
   PubMed Web of Science ®Google Scholar
• Hedenrud T, Håkonsen H. Purchase habits, use of paracetamol, and information sources on a reregulated Swedish pharmacy market: a population-based study. Health Policy. 2017;121:35–41.
   PubMed Web of Science ®Google Scholar
• Rosen S, Ham B, Mogil JS. Sex differences in neuroimmunity and pain. J Neurosci Res. 2017;95:500–508.
   PubMed Web of Science ®Google Scholar
• Håkonsen H, Hedenrud T. A population-based study of risk perceptions of paracetamol use among Swedes - with a special focus on young adults. Pharmacoepidemiol Drug Saf. 2017;26:992–997.
   PubMed Web of Science ®Google Scholar
• Ganther J, Kreling D. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Walsh). 2000;40:378–383.
   Google Scholar
• Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6:93–97
   PubMedGoogle Scholar
• Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82:366–374.
   PubMed Web of Science ®Google Scholar
• Carpman A. Ipren puttar ned Alvedon (Ipren puts down Alvedon). Dagens Medicin; 2016. https://www.dagensmedicin.se/artiklar/2016/05/30/ipren-puttar-ned-alvedon/ [in Swedish] (Accessed 14 augusti 2020)
   Google Scholar
• Ylä-Rautio H, Siissalo S, Leikola S. Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications. Int J Clin Pharm. 2020;42:786–795.
   PubMedGoogle Scholar
• Håkonsen H, Eilertsen M, Borge H, Toverud E-L. Generic substitution - additional challenge for adherence in hypertensive patients? Curr Med Res Opin. 2009;25:2515–2521.
   PubMed Web of Science ®Google Scholar
• Håkonsen H, Toverud EL. Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway. Eur J Clin Pharmacol. 2011;67:193–201.
   PubMed Web of Science ®Google Scholar
• Hanna LA, Hughes CM. Public’s views on making decisions about over-the-counter medication and their attitudes towards evidence of effectiveness: a cross-sectional questionnaire study. Patient Educ Couns. 2011;83:345–351.
   PubMed Web of Science ®Google Scholar
• Schmitt MR, Miller MJ, Harrison DL, Farmer KC, Allison JJ, Cobaugh DJ, et al. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients’ risk awareness. Patient Educ Couns. 2011;83:391–397.
   PubMed Web of Science ®Google Scholar
• McDonald DD, Amendola MG, Interlandi E, Wall K, Lewchik B, Polouse L, et al. Effect of reading additional safety information on planned use of over-the-counter analgesics. Public Health Nurs. 2007;24:230–238.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden (SCB). Utbildningsnivån i Sverige (Educational level in Sweden). https://www.scb.se/hitta-statistik/sverige-i-siffror/utbildning-jobb-och-pengar/utbildningsnivan-i-sverige/ [in Swedish] (Accessed 1 July 2020).
   Google Scholar